查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球单细胞组学市场 2023-2030
市场调查报告书
商品编码
1380386

全球单细胞组学市场 2023-2030

Global Single-Cell Omics Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

预计全球单细胞组学市场在预测期内（2023-2030）将以 18.2% 的CAGR成长。许多癌症中心和全球製药公司越来越多地采用 Tapestri 平台进行转化研究和临床开发，证明了单细胞多组学的必要性。单细胞组学提供了行动解决方案，因为它们可以透过大多数电子设备轻鬆存取。单细胞组学是一个快速发展的领域，在广泛的生物医学研究领域中得到应用。随着该技术变得更加容易获得和负担得起，它正在被全球研究人员采用。

细分市场前景

全球单细胞组学市场按产品类型、应用和最终用户细分。根据产品类型，市场细分为单细胞基因组学、单细胞转录组学、单细胞蛋白质组学和单细胞代谢组学。根据应用，市场细分为肿瘤学、细胞生物学、神经学、免疫学等。根据最终用户，市场细分为製药和生物技术公司、学术和研究组织以及医院和诊断实验室。在最终用户中，由于私营和政府学术和研究组织目前正在进行的研究计画数量激增，预计学术和研究组织细分市场将占据相当大的市场份额。

预计肿瘤学细分市场将在全球单细胞组学市场中占据相当大的份额

其中，肿瘤学细分市场预计将在全球单细胞组学市场中占据相当大的份额。这种细分增长归因于多种因素，例如癌症患病率的增加以及单细胞分析在研究癌症进展中的应用不断增加，预计将推动对组学技术在了解癌症细胞生物学方面的需求。例如，2023年6月，Owkin、Nanostring和全球领先的癌症研究机构匹兹堡大学、Gustave Roussy、洛桑大学医院、Uniklinikum Erlangen/Friedrich-Alexander-Universitat Erlangen-Nurnberg和Charite - Universitatsmedizin Berlin正在推出MOSAIC（MultiOmic空间图谱）在美国临床肿瘤学会年会上。 MOSAIC 是一个耗资 5000 万美元的里程碑式项目，旨在透过使用空间组学彻底改变癌症研究，空间组学是一组尖端技术，可提供有关肿瘤结构的前所未有的信息。

区域展望

全球单细胞组学市场根据地理位置进一步细分，包括北美（美国和加拿大）、欧洲（英国、义大利、西班牙、德国、法国和欧洲其他地区）、亚太地区（印度、中国） 、日本、韩国和亚洲其他地区）以及世界其他地区（中东和非洲以及拉丁美洲）。其中，由于透过单细胞组学进行智慧学习的采用越来越多，预计亚太地区将在全球市场中占据显着份额。

北美地区预计全球单细胞组学市场将以显着的复合CAGR成长

在所有地区中，北美地区预计在预测期内将以相当大的CAGR成长。区域成长归因于医疗基础设施的改善以及市场参与者为更好地研究和产品开发而增加的策略性倡议。例如，2023 年 4 月，高通量单细胞 DNA 和多组学分析领域的先驱 Mission Bio, Inc. 宣布已与 Fulgent Genetics 达成协议，Fulgent Genetics 是一家技术型公司，拥有良好的建立临床诊断业务和治疗开发业务。 Fulgent Genetics 现在能够在Tapestri 平台上透过其完全可客製化的服务菜单提供单细胞多组学，包括全基因组、全外显子组、RNA 定序、肿瘤分析、甲基化测序、液体活检、单细胞测序、空间定序生物学和病理学服务，以满足其不断增长的製药客户需求。此外，Fulgent Genetics 将评估 Tapestri 平台在临床开发中的应用，以简化药物开发和审批流程。

此外，该地区不断增加的投资活动和政府措施也正在推动市场。例如，2023 年 11 月，德州 A&M 大学系统获得了美国国立卫生研究院 (NIH) 的 119 万美元拨款，用于多学科合作，研究基因组学、营养和健康之间的复杂联繫。了解这些关联将有助于癌症和其他疾病的诊断和治疗。

目录

第 1 章：报告摘要

  • 目前行业分析及成长潜力展望
  • 研究方法和工具
  • 市场区隔
    • 按细分
    • 按地区

第 2 章：市场概述与见解

  • 报告范围
  • 分析师见解和当前市场趋势
    • 主要发现
    • 建议
    • 结论

第 3 章：竞争格局

  • 主要公司分析
  • 10x Genomics, Inc.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Bio Rad Laboratories, Inc.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Mission Bio, Inc.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • 关键策略分析

第 4 章：市场细分

  • 按产品类型分類的全球单细胞组学市场
    • 单细胞基因体学
    • 单细胞转录组学
    • 单细胞蛋白质体学
    • 单细胞代谢组学
  • 全球单细胞组学市场（按应用）
    • 肿瘤学
    • 细胞生物学
    • 神经病学
    • 免疫学
    • 其他（微生物学）
  • 按最终用户分類的全球单细胞组学市场
    • 製药和生物技术公司
    • 学术和研究组织
    • 医院和诊断实验室

第 5 章：区域分析

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 西班牙
    • 法国
    • 欧洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 世界其他地区

第 6 章：公司简介

  • Becton, Dickinson and Company
  • Berkeley Lights Inc
  • BGI Genomics Co. Ltd
  • Danaher Corp (Cytiva Life Sciences)
  • Dolomite Bio
  • Epicypher Inc.
  • Fluidigm Corp
  • Illimina, Inc
  • Miltenyi Biotec B.V. & CO.
  • Nanostring Technologies, Inc
  • Olink Holding AB (Olink Proteomics)
  • Parse Bioscience
  • Qiagen N.V.
  • Takara Holdings Inc. Takara Bio Group
  • Thermo Fisher Scientific, Inc.
Product Code: OMR2027795

Title: Global Single-cell omics Market Size, Share & Trends Analysis Report by product Type (Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics, and Single-Cell Metabolomics), by Application (Oncology, Cell Biology, Neurology, Immunology, and Other) and by End User (Pharmaceutical & Biotechnology Companies, Academic and Research Organizations and Hospital and Diagnostic Laboratories),Forecast Period (2023-2030).

The global Single-cell omics market is anticipated to grow at a CAGR of 18.2% during the Forecast Period (2023-2030). The increasing adoption of the Tapestri Platform for translational research and clinical development by many cancer centers and global pharma companies demonstrates the necessity of single-cell multi-omics. Single-cell omics provides mobility solutions as they are easily accessible via most electronic devices. Single-cell omics is a rapidly growing field with applications in a wide range of biomedical research areas. As the technology becomes more accessible and affordable, it is being adopted by researchers globally.

Segmental Outlook

The global Single-cell omics market is segmented on the product type, application, and end user. Based on the product type, the market is sub-segmented into single-cell genomics, single-cell transcriptomics, single-cell proteomics, and single-cell metabolomics. Based on application, the market is sub-segmented into oncology, cell biology, neurology, immunology and other. And based on the end user, the market is sub-segmented into pharmaceutical & biotechnology companies, academic and research organizations and hospital and diagnostic laboratories. among the end user, the academic and research organizations sub-segment is anticipated to hold a considerable share of the market, owing to the spike in the number of research projects that are currently underway at private and government academic and research organizations.

The Oncology Sub-Segment is Anticipated to Hold a Considerable Share of the Global Single-cell omics Market

Among the application, the Oncology sub-segment is expected to hold a considerable share of the global Single-cell omics market. This segmental growth is attributed to several factor such as, increasing prevalence of cancer and rising applications of single-cell analysis in studying cancer progression is projected to fuel the demand for omics technology in understanding the cell biology of cancer. For instance, In June 2023, Owkin, Nanostring and world-leading cancer research institutions University of Pittsburgh, Gustave Roussy, Lausanne University Hospital, Uniklinikum Erlangen/Friedrich-Alexander-Universitat Erlangen-Nurnberg, and Charite - Universitatsmedizin Berlin are launching MOSAIC (Multi Omic Spatial Atlas In Cancer) at the American Society of Clinical Oncology's annual meeting. MOSAIC is a landmark $50 million project to revolutionize cancer research through the use of spatial omics, a set of cutting-edge technologies that offer unprecedented information on the structure of tumors.

Regional Outlook

The global Single-cell omics market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia pacific is anticipated to hold a prominent share of the market across the globe, owing to growing adoption of smart learning through Single-cell omics.

The North America Region is Expected to Grow at a Significant CAGR in the Global Single-cell omics Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to improving medical infrastructure and increasing strategic initiatives by market player for better research and product development in the regions. For instance, in April 2023, Mission Bio, Inc., the pioneer in high-throughput single-cell DNA and multi-omics analysis, announced that it has entered into an agreement with Fulgent Genetics, a technology-based company with a well-established clinical diagnostic business and a therapeutic development business. Fulgent Genetics is now able to offer single-cell multi-omics on the Tapestri Platform on its fully customizable menu of services, including whole genome, whole exome, RNA sequencing, tumor profiling, methylation sequencing, liquid biopsy, single-cell sequencing, spatial biology, and pathology services to support its growing pharma client demands. Additionally, Fulgent Genetics will evaluate the Tapestri Platform for applications in clinical development to streamline the drug development and approval process.

Also, increasing investing activities and government initiatives in the region, are also driving the market. For instance, in November 2023, The Texas A&M University System has received a $1.19 million grant from the National Institutes of Health (NIH) for a multidisciplinary collaboration to study the intricate connections between genomics, nutrition and health. Understanding these connections will help in the diagnosis and treatment of cancer and other diseases.

Market Players Outlook

The major companies serving the Single-cell omics market include: Becton, Dickinson and Company, Berkeley Lights Inc, BGI Genomics Co. Ltd, Danaher Corp, Dolomite Bio, Epicypher Inc., Fluidigm Corp, Illimina, Inc, Miltenyi Biotec B.V. & CO., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, In August 2023, Scale Biosciences, Inc. announced an expansion of their product portfolio to enable a broader range of single cell omics experiments and unlock new translational research applications. New products include the ScaleBio Single Cell Methylation Kit, ScaleBio Single Cell CRISPR Guide Enrichment Kit, Scale-plex Kit, and additional capabilities for the company's existing ScaleBio Single Cell RNA Sequencing Kit to facilitate more diverse experimental designs and broader use of translational samples leveraging innovative, scalable, and accessible tools to democratize single cell omics across research applications without the need for additional instrumentation.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global Single-cell omics market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. 10x Genomics, Inc.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Bio Rad Laboratories, Inc.
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Mission Bio, Inc.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Single-cell Omics Market by Product Type
    • 4.1.1. Single-Cell Genomics
    • 4.1.2. Single-Cell Transcriptomics
    • 4.1.3. Single-Cell Proteomics
    • 4.1.4. Single-Cell Metabolomics
  • 4.2. Global Single-cell Omics Market by Application
    • 4.2.1. Oncology
    • 4.2.2. Cell Biology
    • 4.2.3. Neurology
    • 4.2.4. Immunology
    • 4.2.5. other (Microbiology)
  • 4.3. Global Single-cell Omics Market by End-User
    • 4.3.1. Pharma and biotech companies
    • 4.3.2. Academic and Research Organizations
    • 4.3.3. Hospital and Diagnostic Laboratories

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Becton, Dickinson and Company
  • 6.2. Berkeley Lights Inc
  • 6.3. BGI Genomics Co. Ltd
  • 6.4. Danaher Corp (Cytiva Life Sciences)
  • 6.5. Dolomite Bio
  • 6.6. Epicypher Inc.
  • 6.7. Fluidigm Corp
  • 6.8. Illimina, Inc
  • 6.9. Miltenyi Biotec B.V. & CO.
  • 6.10. Nanostring Technologies, Inc
  • 6.11. Olink Holding AB (Olink Proteomics)
  • 6.12. Parse Bioscience
  • 6.13. Qiagen N.V.
  • 6.14. Takara Holdings Inc. Takara Bio Group
  • 6.15. Thermo Fisher Scientific, Inc.

LIST OF TABLES

  • 1. GLOBAL SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022-2030 ($ MILLION)
  • 2. GLOBAL GENOMICS SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 3. GLOBAL TRANSCRIPTOMICS SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL PROTEOMICS SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL METABOLOMICS SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 7. GLOBAL ONCOLOGY IN SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 8. GLOBAL CELL BIOLOGY IN SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 9. GLOBAL NEUROLOGY IN SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 10. GLOBAL IMMUNOLOGY IN SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 11. GLOBAL OTHER APPLICATIONS IN SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 12. GLOBAL SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 13. GLOBAL SINGLE-CELL OMICS FOR PHARMA AND BIOTECH COMPANIES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 14. GLOBAL SINGLE-CELL OMICS FOR ACADEMIC AND RESEARCH ORGANIZATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 15. GLOBAL SINGLE-CELL OMICS FOR HOSPITAL AND DIAGNOSTIC LABORATORIES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 16. GLOBAL SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 17. NORTH AMERICAN SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 18. NORTH AMERICAN SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022-2030 ($ MILLION)
  • 19. NORTH AMERICAN SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 20. NORTH AMERICAN SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 21. EUROPEAN SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 22. EUROPEAN SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022-2030 ($ MILLION)
  • 23. EUROPEAN SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 24. EUROPEAN SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 25. ASIA- PACIFIC SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 26. ASIA- PACIFIC SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022-2030 ($ MILLION)
  • 27. ASIA- PACIFIC SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 28. ASIA- PACIFIC SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 29. REST OF THE WORLD SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 30. REST OF THE WORLD SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022-2030 ($ MILLION)
  • 31. REST OF THE WORLD SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 32. REST OF THE WORLD SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL SINGLE-CELL OMICS MARKET SHARE BY PRODUCT TYPE, 2022 VS 2030 (%)
  • 2. GLOBAL GENOMICS SINGLE-CELL OMICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL TRANSCRIPTOMICS SINGLE-CELL OMICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL PROTEOMICS SINGLE-CELL OMICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL METABOLOMICS SINGLE-CELL OMICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL SINGLE-CELL OMICS MARKET SHARE BY APPLICATION, 2022 VS 2030 (%)
  • 7. GLOBAL ONCOLOGY SINGLE-CELL OMICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL CELL BIOLOGY REALITY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL NEUROLOGY SINGLE-CELL OMICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL IMMUNOLOGY SINGLE-CELL OMICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL OTHER APPLICATIONS SINGLE-CELL OMICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL SINGLE-CELL OMICS MARKET SHARE BY END-USER, 2022 VS 2030 (%)
  • 13. GLOBAL SINGLE-CELL OMICS FOR PHARMA AND BIOTECH COMPANIES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 14. GLOBAL SINGLE-CELL OMICS FOR ACADEMIC AND RESEARCH ORGANIZATIONS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 15. GLOBAL SINGLE-CELL OMICS FOR HOSPITAL AND DIAGNOSTIC LABORATORIES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 16. GLOBAL SINGLE-CELL OMICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 17. US SINGLE-CELL OMICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. CANADA SINGLE-CELL OMICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. UK SINGLE-CELL OMICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. FRANCE SINGLE-CELL OMICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. GERMANY SINGLE-CELL OMICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. ITALY SINGLE-CELL OMICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. SPAIN SINGLE-CELL OMICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. REST OF EUROPE SINGLE-CELL OMICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. INDIA SINGLE-CELL OMICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. CHINA SINGLE-CELL OMICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. JAPAN SINGLE-CELL OMICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. SOUTH KOREA SINGLE-CELL OMICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 29. REST OF ASIA-PACIFIC SINGLE-CELL OMICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 30. REST OF THE WORLD SINGLE-CELL OMICS MARKET SIZE, 2022-2030 ($ MILLION)